Royal Bank of Canada
TECX

Royal Bank of Canada’s Tectonic Therapeutic TECX Stock Holding History

Royal Bank of Canada’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-521
Closed -$10K – 7806
2025
Q4 		$10K Buy
521
+235
+82% +$4.37K ﹤0.01% 6436
2025
Q3 		$5K Sell
286
-396
-58% -$8.17K ﹤0.01% 6721
2025
Q2 		$14K Sell
682
-6,318
-90% -$128K ﹤0.01% 6388
2025
Q1 		$124K Buy
+7,000
New +$228K ﹤0.01% 5080
2024
Q4 		– Sell
-155
Closed -$5K – 7336
2024
Q3 		$5K Sell
155
-2
-1% -$37 ﹤0.01% 6525
2024
Q2 		$3K Sell
157
-1
-0.6% -$16 ﹤0.01% 6687
2024
Q1 		$2K Hold
158
– – ﹤0.01% 6720
2023
Q4 		$3K Sell
158
-7
-4% -$120 ﹤0.01% 6761
2023
Q3 		$3K Sell
165
-29
-15% -$513 ﹤0.01% 6746
2023
Q2 		$2K Buy
194
+39
+25% +$441 ﹤0.01% 6916
2023
Q1 		$2K Hold
155
– – ﹤0.01% 6812
2022
Q4 		$1K Sell
155
-33
-18% -$290 ﹤0.01% 7097
2022
Q3 		$1K Buy
188
+25
+15% +$278 ﹤0.01% 7301
2022
Q2 		$2K Sell
163
-186
-53% -$2.19K ﹤0.01% 7012
2022
Q1 		$5K Sell
349
-438
-56% -$9.05K ﹤0.01% 7271
2021
Q4 		$36K Buy
787
+300
+62% +$17.2K ﹤0.01% 6556
2021
Q3 		$32K Sell
487
-69,392
-99% -$5.69M ﹤0.01% 6432
2021
Q2 		$7.46M Buy
69,879
+69,523
+19,529% +$8.24M ﹤0.01% 2015
2021
Q1 		$55K Buy
356
+188
+112% +$30.6K ﹤0.01% 5826
2020
Q4 		$28K Buy
168
+13
+8% +$2.31K ﹤0.01% 5912
2020
Q3 		$24K Sell
155
-5
-3% -$1.01K ﹤0.01% 5630
2020
Q2 		$34K Sell
160
-5
-3% -$1.03K ﹤0.01% 5384
2020
Q1 		$31K Buy
165
+50
+43% +$11.8K ﹤0.01% 5374
2019
Q4 		$28K Buy
+115
New +$22.2K ﹤0.01% 5718
2019
Q1 		– Sell
-5
Closed -$1K – 7161
2018
Q4 		$1K Sell
5
-5
-50% -$1.52K ﹤0.01% 6626
2018
Q3 		$6K Buy
+10
New +$4.43K ﹤0.01% 6210

Other funds holding TECX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Royal Bank of Canada's TECX Position: Q1 2026 in Review

Royal Bank of Canada sold out of Tectonic Therapeutic (TECX) in Q1 2026, closing a stake of 521 shares — an estimated $10K sold.

Royal Bank of Canada first reported a position in TECX in Q3 2018 and held it in 26 quarters. The position peaked at $7.46M in Q2 2021. 111 funds tracked by Wall St. Rank hold TECX as of Q1 2026.

  • Royal Bank of Canada reported no remaining Tectonic Therapeutic position as of Q1 2026 after selling out during the quarter.
  • Royal Bank of Canada sold 521 Tectonic Therapeutic shares in Q1 2026, an estimated $10K.
  • Royal Bank of Canada first reported a position in Tectonic Therapeutic in Q3 2018 and held it in 26 quarters.
  • Royal Bank of Canada's Tectonic Therapeutic position peaked at $7.46M in Q2 2021.
  • 111 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.